Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.840
-0.150 (-3.76%)
At close: Nov 16, 2026, 4:00 PM EST
3.925
+0.085 (2.20%)
After-hours: Nov 16, 2026, 7:59 PM EST

Nuvation Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-135.93-204.63-567.94-75.8-104.2-86.85
Depreciation & Amortization
2.191.740.680.220.20.18
Other Amortization
1.530.66----
Loss (Gain) From Sale of Assets
00.030.230.010.05-
Asset Writedown & Restructuring Costs
--425.07--3.79
Loss (Gain) From Sale of Investments
-3.91-5.29-8.99-11.924.94.67
Stock-Based Compensation
37.5535.8932.2819.5116.299.27
Other Operating Activities
26.7310.140.76-0.56-9.9-4.05
Change in Accounts Receivable
-28.22-3.35-12.72---
Change in Inventory
-9.63-11.41----
Change in Accounts Payable
-5.413.13-1.650.07-1.791.86
Change in Unearned Revenue
-2.14-7.873.94---
Change in Other Net Operating Assets
11.057.52-2.070.47-1.662.93
Operating Cash Flow
-106.19-173.43-130.41-68-96.11-68.19
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.98-0.35-0.16-0.07-0.37-0.28
Sale of Property, Plant & Equipment
---0.010.01-
Cash Acquisitions
--12.43---
Sale (Purchase) of Intangibles
--8----
Investment in Securities
-57.93107.87110.448.9863.81-454.39
Investing Cash Flow
-59.9199.52122.78.9263.46-454.67

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-210.112.61---
Total Debt Issued
291.52210.112.61---
Long-Term Debt Repaid
--12.39-17.16---
Total Debt Repaid
-73.47-12.39-17.16---
Net Debt Issued (Repaid)
218.05197.71-4.55---
Issuance of Common Stock
22.0911.424.890.631.330.76
Other Financing Activities
-18.34-6.6---624.77
Financing Cash Flow
221.8202.540.330.631.33625.53

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.83-0.270.45---
Net Cash Flow
54.87128.36-6.93-58.45-31.32102.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-108.17-173.78-130.58-68.07-96.48-68.47
Free Cash Flow Growth
------
Free Cash Flow Margin
-53.62%-276.27%-1658.52%---
Free Cash Flow Per Share
-0.31-0.51-0.49-0.31-0.45-0.35
Levered Free Cash Flow
-76.06-115.78-52.19-41.59-62.44-39.03
Unlevered Free Cash Flow
-61.19-107.89-51.97-41.59-62.44-39.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-34.36-11.98-12.510.54-3.454.79
SEC Filings: 10-K · 10-Q